449 related articles for article (PubMed ID: 19201471)
1. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
Coetsier CM; Spinelli S; Lin L; Roig B; Touraud E
Environ Int; 2009 Jul; 35(5):787-92. PubMed ID: 19201471
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
Boyd GR; Reemtsma H; Grimm DA; Mitra S
Sci Total Environ; 2003 Jul; 311(1-3):135-49. PubMed ID: 12826389
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
Liebig M; Moltmann JF; Knacker T
Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
[TBL] [Abstract][Full Text] [Related]
4. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
Choi K; Kim Y; Park J; Park CK; Kim M; Kim HS; Kim P
Sci Total Environ; 2008 Nov; 405(1-3):120-8. PubMed ID: 18684486
[TBL] [Abstract][Full Text] [Related]
5. The occurrence and distribution of pharmaceutical compounds in the effluents of a major sewage treatment plant in Northern Taiwan and the receiving coastal waters.
Fang TH; Nan FH; Chin TS; Feng HM
Mar Pollut Bull; 2012 Jul; 64(7):1435-44. PubMed ID: 22608946
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
7. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
Christensen AM; Markussen B; Baun A; Halling-Sørensen B
Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
[TBL] [Abstract][Full Text] [Related]
8. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska.
Bartelt-Hunt SL; Snow DD; Damon T; Shockley J; Hoagland K
Environ Pollut; 2009 Mar; 157(3):786-91. PubMed ID: 19110357
[TBL] [Abstract][Full Text] [Related]
9. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage.
Carballa M; Omil F; Lema JM
Chemosphere; 2008 Jul; 72(8):1118-23. PubMed ID: 18514761
[TBL] [Abstract][Full Text] [Related]
10. Prediction of carbamazepine in sewage treatment plant effluents and its implications for control strategies of pharmaceutical aquatic contamination.
Zhang Y; Geissen SU
Chemosphere; 2010 Sep; 80(11):1345-52. PubMed ID: 20594577
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical and personal care products (PPCPs) in urban receiving waters.
Ellis JB
Environ Pollut; 2006 Nov; 144(1):184-9. PubMed ID: 16500738
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents.
Fick J; Lindberg RH; Parkkonen J; Arvidsson B; Tysklind M; Larsson DG
Environ Sci Technol; 2010 Apr; 44(7):2661-6. PubMed ID: 20222725
[TBL] [Abstract][Full Text] [Related]
13. Predicting variability of aquatic concentrations of human pharmaceuticals.
Kostich MS; Batt AL; Glassmeyer ST; Lazorchak JM
Sci Total Environ; 2010 Sep; 408(20):4504-10. PubMed ID: 20619877
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
15. An environmental risk assessment for oseltamivir (Tamiflu) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions.
Straub JO
Ecotoxicol Environ Saf; 2009 Sep; 72(6):1625-34. PubMed ID: 19560203
[TBL] [Abstract][Full Text] [Related]
16. Drugs, diagnostic agents and disinfectants in wastewater and water--a review.
Kümmerer K
Schriftenr Ver Wasser Boden Lufthyg; 2000; 105():59-71. PubMed ID: 10842795
[TBL] [Abstract][Full Text] [Related]
17. The presence of acidic and neutral drugs in treated sewage effluents and receiving waters in the Cornwallis and Annapolis River watersheds and the Mill CoveSewage Treatment Plant in Nova Scotia, Canada.
Crouse BA; Ghoshdastidar AJ; Tong AZ
Environ Res; 2012 Jan; 112():92-9. PubMed ID: 22178020
[TBL] [Abstract][Full Text] [Related]
18. Elimination of pharmaceuticals in sewage treatment plants in Finland.
Vieno N; Tuhkanen T; Kronberg L
Water Res; 2007 Mar; 41(5):1001-12. PubMed ID: 17261324
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment.
Tauxe-Wuersch A; De Alencastro LF; Grandjean D; Tarradellas J
Water Res; 2005 May; 39(9):1761-72. PubMed ID: 15899274
[TBL] [Abstract][Full Text] [Related]
20. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
